The purpose of this study is to determine how the prospect of direct benefit to research subjects in gene transfer research (GTR)(usually called gene therapy) is understood and discussed by research subjects, investigators, study coordinators, and IRBs, and explained in consent forms. The investigators expect to find that the prospect of benefit from receiving the investigational intervention is often exaggerated; they expect to find that this exaggeration of benefit is accompanied by language confusion in consent forms, blending of the roles of physician and researcher, and other aspects of the review of research and the consent process. To investigate these issues, they propose to interview investigators, study coordinators, and subjects in up to 40 recent GTR studies, to analyze consent forms and protocols for all GTR studies approved since 1990 (n=about 275), and to interview IRBs at institutions overseeing the 40 studies. The investigators will develop a model that explains the variation in participants understanding and discussion of benefit from GTR interventions, controlling for contextual factors, within and between these studies. They will separately assess variation in understanding and discussion of benefit in consent forms and by IRBs. They hope to discover some ways of reducing the tendency toward exaggeration of benefit by careful attention to language in the consent form and process, by education of investigators and IRB members, and by consideration of how the context in which GTR takes place can affect the understanding of the parties to this research. Based on their findings, they hope to develop an improved policy standard for the presentation of benefit in GTR specifically and clinical research generally.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project (R01)
Project #
5R01HG002087-02
Application #
6181818
Study Section
Special Emphasis Panel (ZRG1-GNM (01))
Program Officer
Boyer, Joy
Project Start
1999-09-30
Project End
2002-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
2
Fiscal Year
2000
Total Cost
$333,412
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Henderson, Gail E (2011) Is informed consent broken? Am J Med Sci 342:267-72
Schaffer, Rebecca; Henderson, Gail E; Churchill, Larry R et al. (2009) Parents' online portrayals of pediatric treatment and research options. J Empir Res Hum Res Ethics 4:73-87
Henderson, Gail E; Churchill, Larry R; Davis, Arlene M et al. (2007) Clinical trials and medical care: defining the therapeutic misconception. PLoS Med 4:e324
Henderson, Gail E; Easter, Michele M; Zimmer, Catherine et al. (2006) Therapeutic misconception in early phase gene transfer trials. Soc Sci Med 62:239-53
Easter, Michele M; Henderson, Gail E; Davis, Arlene M et al. (2006) The many meanings of care in clinical research. Sociol Health Illn 28:695-712
King, Nancy M P; Henderson, Gail E; Churchill, Larry R et al. (2005) Consent forms and the therapeutic misconception: the example of gene transfer research. IRB 27:1-8
Churchill, Larry R; Nelson, Daniel K; Henderson, Gail E et al. (2003) Assessing benefits in clinical research: why diversity in benefit assessment can be risky. IRB 25:1-8
Davis, Arlene M; Hull, Sara Chandros; Grady, Christine et al. (2002) The invisible hand in clinical research: the study coordinator's critical role in human subjects protection. J Law Med Ethics 30:411-9